Shuyang Zhang
Shuyang Zhang, MD, PhD, FACC, Professor, Physician, Supervisor, Department of Cardiology; Director of Clinical Pharmacology Research Center, Vice Director of Translational Research Center and Vice President at Peking Union Medical College Hospital (PUMCH); Vice Chancellor, Chinese Academy of Medical Sciences & Peking Union Medical College.
Professor Zhang has rich experiences in diagnosis and treatment of various cardiovascular diseases, including rare and complicated cases. She specialized at screening, diagnosing and treatment of coronary heart disease, hypertension, dyslipidemia, diabetes and metabolic syndrome. Her expertise in patient care and clinical research has been widely recognized by patients and peers.
Research Focus:
Focusing on coronary heart disease and a variety of diseases caused by vascular damage, Dr. Zhang is actively leading and participating in national and provincial level research projects in basic and clinical research. Since the 1980’s, Dr. Zhang has joined dozens of global multi-center clinical trials.
Professor Zhang is the Executive Director of the Chinese Medical Association (CMA), Vice Director of the Internal Medicine Committee, CMA; Vice Director of Clinical Pharmaceutical Committee, CMA; Director of Clinical Pharmaceutical Committee, Beijing Committee,CMA; Member of Cardiovascular Disease Committee, CMA; Executive Director of China Hypertension Alliance, etc.
Social Positions:
Dr. Zhang has served as editors of more than 10 medical journals,including Chinese Journal of Internal Medicine and Chinese Journal of Cardiology. Currently, she serves as one of the Chief experts of Public Welfare Funding of the National Health and Family Planning Commission, and the Chief expert of Rare Disease Cohort Study of the 13th Five-Year National Precision Medical Research and Development Planning.
Professor Zhang has rich experiences in diagnosis and treatment of various cardiovascular diseases, including rare and complicated cases. She specialized at screening, diagnosing and treatment of coronary heart disease, hypertension, dyslipidemia, diabetes and metabolic syndrome. Her expertise in patient care and clinical research has been widely recognized by patients and peers.
Research Focus:
Focusing on coronary heart disease and a variety of diseases caused by vascular damage, Dr. Zhang is actively leading and participating in national and provincial level research projects in basic and clinical research. Since the 1980’s, Dr. Zhang has joined dozens of global multi-center clinical trials.
Professor Zhang is the Executive Director of the Chinese Medical Association (CMA), Vice Director of the Internal Medicine Committee, CMA; Vice Director of Clinical Pharmaceutical Committee, CMA; Director of Clinical Pharmaceutical Committee, Beijing Committee,CMA; Member of Cardiovascular Disease Committee, CMA; Executive Director of China Hypertension Alliance, etc.
Social Positions:
Dr. Zhang has served as editors of more than 10 medical journals,including Chinese Journal of Internal Medicine and Chinese Journal of Cardiology. Currently, she serves as one of the Chief experts of Public Welfare Funding of the National Health and Family Planning Commission, and the Chief expert of Rare Disease Cohort Study of the 13th Five-Year National Precision Medical Research and Development Planning.
